Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program
<h4>Objective</h4> To assess baseline characteristics and antithrombotic treatment (ATT) prescription patterns in patients enrolled in the third phase of the GLORIA-AF Registry Program, evaluate predictors of treatment prescription, and compare results with phase II. <h4>Methods<...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Public Library of Science (PLoS)
2022-01-01
|
Colección: | PLoS ONE |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536607/?tool=EBI |